1.
|
Phase: Phase IV
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 123omega, VN2005/35, NCT00488904
|
|
2.
|
Phase: Phase III
Type: Prevention
Status: Active
Age: 40 to 80
Sponsor: NCI
Protocol IDs: UARIZ-00-0430-01, 00-0430-01, UARIZ-HSC-00142, NCT00078897
|
|
3.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CA101770, NCT00230646
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: tasmc-05-na-05160-ctil, NCT00295035
|
|
5.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 06.23.CLI, NCT00455247
|
|
6.
|
Phase: Phase III
Type: Natural history/Epidemiology, Prevention
Status: Active
Age: 50 and over
Sponsor: NCI
Protocol IDs: SWOG-S0000D, S0000D, NCT00706121
|
|
7.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UCI 05-20, NCT00256334
|
|
8.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 0706002781, ACS IRG 58-012-49, NCT00730158
|
|
9.
|
Phase: Phase II
Type: Prevention
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 802193, NCT00118989
|
|
10.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ML18581, The "lactAXE" trial, NCT00197873
|
|
11.
|
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GI-05-0024, NCT00255229
|
|
12.
|
Phase: Phase II
Type: Prevention
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: 23266, KUN 2003-2911, NCT00319007
|
|
13.
|
Phase: Phase II
Type: Supportive care
Status: Active
Age: Over 18
Sponsor: NCI
Protocol IDs: MSKCC-06145, NCT00425412
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 80
Sponsor: Other
Protocol IDs: Flav-Hoe-CCR, NCT00609310
|
|
15.
|
Phase: Phase II
Type: Educational/Counseling/Training
Status: Active
Age: 19 and over
Sponsor: Other
Protocol IDs: SU-07292009-3460, VAR0044, NCT00962494
|
|
16.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Over 18
Sponsor: NCI
Protocol IDs: CCUM-TASK2B, LRI-6930, N01-CN-25025-4, NCT00433576
|
|
17.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 50 and over
Sponsor: NCI
Protocol IDs: NU-08I3, NU 08I3, NCT00870961
|
|
18.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: CINJ-120901, 120901, IRB#0220090065, NCT00905918
|
|
19.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: LRI-UL-CURCUMIN, UL-CURCUMIN, EUDRACT-2007-001971-13, EU-20961, NCT00973869
|
|
20.
|
Phase: No phase specified
Type: Behavioral study, Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: #2000-007, NCI R03 CA88598-01A1, NCT00179348
|
|
21.
|
Phase: No phase specified
Type: Behavioral study, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IRB #2003-412, ACS Research Scholar's Grant, NCT00179387
|
|
22.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: 2004-064, NCT00444054
|
|
23.
|
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: Seigen Safety Trial: Cancer, WIRB Study No. 1085894, WIRB Pr. No. 20062258, NCT00606970
|
|
24.
|
Phase: No phase specified
Type: Educational/Counseling/Training, Supportive care
Status: Active
Age: Over 18
Sponsor: NCI
Protocol IDs: MGH-2007-P-000368, 2007-P-000368, NCT00706290
|
|
25.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: WJB730603, NCT00689364
|
